Note for the rapporteurs/shadow rapporteurs of the EU Pharmaceutical legislation: Impact of extending the duration of regulatory data protection in the new EU pharmaceutical legislation
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok